The review discussed that overall, NPY levels were significantly lower in plasma and cerebrospinal fluid in PTSD patients versus controls and that patients with MDD had significantly lower levels of NPY in plasma compared to controls, but not in the CSF. The gene discussed is NPY; the disease is major depressive disorder.